Global Butylated Hydroxyanisole Market Overview:
Butylated hydroxyanisole (BHA), an antioxidant that contain a mixture of two isomeric organic compounds, 2-tert-butyl-4-hydroxyanisole & 3-tert-butyl-4-hydroxyanisole. From 4-methoxyphenol and isobutylene, it is prepared. This waxy solid is used as a food additive with the E number E320. The main use for BHA is as an antioxidant as well as preservative in food, animal feed, food packaging, cosmetics, rubber, as well as petroleum products. BHA also is normally used in medicines, like lovastatin, isotretinoin, and simvastatin, among others. Increasing demand from end use industries is likely to impel the market growth.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Historical Period | 2017-2021 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Butylated Hydroxyanisole Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Growing Adoption in Food Industry
- Increasing Use in End Use Industries
|
Restraints | - Strict Regulations for the Use of BHA in Commercial Food Products
|
Gaps & Opportunities | - Growing Usage in Many Industries
- Increasing Opportunities from Untapped Markets
|
Competitive Landscape:
Some of the key players profiled in the report are Eastman Chemical Company (United States), Clean Science and Technology Private Limited. (India), Merck KGaA (United States), Lanxess Aktiengesellschaft (Germany), Abcam plc (United Kingdom), Ratnagiri Chemicals Pvt Ltd. (India), Crystal Quinone Pvt. Ltd., (India), Finoric LLC (United States), Spectrum Chemical Manufacturing Corp. (India) and Anmol Chemicals (India). Additionally, following companies can also be profiled that are part of our coverage like Shiv Shakti Trading Corporation (India). Analyst at AMA Research see Indian, German, and Unites States Vendors to retain maximum share of Global Butylated Hydroxyanisole market by 2027. Considering Market by Grade, the sub-segment i.e. Food Grade BHA will boost the Butylated Hydroxyanisole market. Considering Market by End Use Industries, the sub-segment i.e. Rubber/Plastic Industry will boost the Butylated Hydroxyanisole market. Considering Market by Form Type, the sub-segment i.e. Crystal will boost the Butylated Hydroxyanisole market.
The United States National Institutes of Health report that BHA is sensibly anticipated to be a human carcinogen on the basis of evidence of carcinogenicity in experimental animals. Particularly, when administered in high doses as part of their diet, BHA origins papillomas & squamous cell carcinomas of the forestomach in rats & Syrian golden hamsters. With examining human population statistics, the normal low intake levels of BHA show no significant association with an increased risk of cancer. The State of California has though, listed it as a carcinogen. These factors are likely to impact market growth.
What Can be Explored with the Butylated Hydroxyanisole Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Butylated Hydroxyanisole Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Butylated Hydroxyanisole
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Butylated Hydroxyanisole market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Butylated Hydroxyanisole market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Butylated Hydroxyanisole Manufacturers, Raw Materials Suppliers, Government and Research Organizations, Industry Associations, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.